CA2302116A1 - Dispositif de soutien d'un transplant - Google Patents

Dispositif de soutien d'un transplant Download PDF

Info

Publication number: CA2302116A1
Authority: CA; Canada
Prior art keywords: capsule; graft; distal; assembly; catheter
Prior art date: 1994-05-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002302116A

Other languages

English (en)

Inventor

Dinah B. Quiachon

Alec A. Piplani

Richard S. Williams

Steve G. Baker

Peter K. Johansson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Endovascular Technologies Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-12

Filing date

1994-08-15

Publication date

1995-11-13

1994-05-12 Priority claimed from US08/241,476 external-priority patent/US5628783A/en

1994-08-15 Application filed by Individual filed Critical Individual

1994-08-15 Priority claimed from CA002257663A external-priority patent/CA2257663C/fr

1995-11-13 Publication of CA2302116A1 publication Critical patent/CA2302116A1/fr

Status Abandoned legal-status Critical Current

Links

239000002775 capsule Substances 0.000 claims abstract description 341
238000000034 method Methods 0.000 claims abstract description 28
239000000463 material Substances 0.000 claims description 30
239000012530 fluid Substances 0.000 claims description 20
210000005166 vasculature Anatomy 0.000 claims description 12
230000008439 repair process Effects 0.000 claims description 11
238000004891 communication Methods 0.000 claims description 8
230000006835 compression Effects 0.000 claims description 6
238000007906 compression Methods 0.000 claims description 6
238000004873 anchoring Methods 0.000 claims description 5
230000007797 corrosion Effects 0.000 claims description 2
238000005260 corrosion Methods 0.000 claims description 2
230000003014 reinforcing effect Effects 0.000 claims 1
230000003447 ipsilateral effect Effects 0.000 abstract description 79
230000000712 assembly Effects 0.000 abstract description 12
238000000429 assembly Methods 0.000 abstract description 12
230000007704 transition Effects 0.000 abstract description 10
239000007943 implant Substances 0.000 abstract description 6
241001465754 Metazoa Species 0.000 abstract description 2
230000003187 abdominal effect Effects 0.000 abstract description 2
239000012528 membrane Substances 0.000 abstract 1
239000003550 marker Substances 0.000 description 30
210000003090 iliac artery Anatomy 0.000 description 29
-1 polyethylene Polymers 0.000 description 14
210000000709 aorta Anatomy 0.000 description 13
210000001105 femoral artery Anatomy 0.000 description 13
238000002594 fluoroscopy Methods 0.000 description 13
206010002329 Aneurysm Diseases 0.000 description 11
208000037595 EN1-related dorsoventral syndrome Diseases 0.000 description 11
239000004698 Polyethylene Substances 0.000 description 11
230000036961 partial effect Effects 0.000 description 11
229920000573 polyethylene Polymers 0.000 description 11
229910001220 stainless steel Inorganic materials 0.000 description 8
239000005020 polyethylene terephthalate Substances 0.000 description 7
239000010935 stainless steel Substances 0.000 description 7
239000000853 adhesive Substances 0.000 description 6
230000001070 adhesive effect Effects 0.000 description 6
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical group [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
230000000717 retained effect Effects 0.000 description 6
210000000702 aorta abdominal Anatomy 0.000 description 5
210000001367 artery Anatomy 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
229920000139 polyethylene terephthalate Polymers 0.000 description 5
238000010926 purge Methods 0.000 description 5
208000007474 aortic aneurysm Diseases 0.000 description 4
238000002788 crimping Methods 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
229920000728 polyester Polymers 0.000 description 4
235000018936 Vitellaria paradoxa Nutrition 0.000 description 3
210000003484 anatomy Anatomy 0.000 description 3
230000008901 benefit Effects 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
230000017531 blood circulation Effects 0.000 description 3
238000010276 construction Methods 0.000 description 3
238000002513 implantation Methods 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000004033 plastic Substances 0.000 description 3
229910052697 platinum Inorganic materials 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
210000005239 tubule Anatomy 0.000 description 3
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
229920001651 Cyanoacrylate Polymers 0.000 description 2
229920004934 Dacron® Polymers 0.000 description 2
241000490229 Eucephalus Species 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
229920002614 Polyether block amide Polymers 0.000 description 2
229910001080 W alloy Inorganic materials 0.000 description 2
TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
239000000560 biocompatible material Substances 0.000 description 2
230000023555 blood coagulation Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
208000014674 injury Diseases 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
229920009441 perflouroethylene propylene Polymers 0.000 description 2
ZONODCCBXBRQEZ-UHFFFAOYSA-N platinum tungsten Chemical compound [W].[Pt] ZONODCCBXBRQEZ-UHFFFAOYSA-N 0.000 description 2
229920000515 polycarbonate Polymers 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920001343 polytetrafluoroethylene Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
210000002254 renal artery Anatomy 0.000 description 2
238000007789 sealing Methods 0.000 description 2
230000008733 trauma Effects 0.000 description 2
229910000014 Bismuth subcarbonate Inorganic materials 0.000 description 1
101100452236 Caenorhabditis elegans inf-1 gene Proteins 0.000 description 1
241000459479 Capsula Species 0.000 description 1
241000727194 Eurys Species 0.000 description 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
241000272168 Laridae Species 0.000 description 1
241001327631 Meara Species 0.000 description 1
241000353097 Molva molva Species 0.000 description 1
229910000990 Ni alloy Inorganic materials 0.000 description 1
102000002508 Peptide Elongation Factors Human genes 0.000 description 1
108010068204 Peptide Elongation Factors Proteins 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
238000007792 addition Methods 0.000 description 1
230000003872 anastomosis Effects 0.000 description 1
238000002583 angiography Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000004872 arterial blood pressure Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
MGLUJXPJRXTKJM-UHFFFAOYSA-L bismuth subcarbonate Chemical compound O=[Bi]OC(=O)O[Bi]=O MGLUJXPJRXTKJM-UHFFFAOYSA-L 0.000 description 1
229940036358 bismuth subcarbonate Drugs 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
SZMZREIADCOWQA-UHFFFAOYSA-N chromium cobalt nickel Chemical compound [Cr].[Co].[Ni] SZMZREIADCOWQA-UHFFFAOYSA-N 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
230000002542 deteriorative effect Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 1
230000010102 embolization Effects 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
239000000835 fiber Substances 0.000 description 1
229920002457 flexible plastic Polymers 0.000 description 1
230000006870 function Effects 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
230000002439 hemostatic effect Effects 0.000 description 1
238000007373 indentation Methods 0.000 description 1
238000002608 intravascular ultrasound Methods 0.000 description 1
230000001050 lubricating effect Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
229910001000 nickel titanium Inorganic materials 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
239000000523 sample Substances 0.000 description 1
238000009958 sewing Methods 0.000 description 1
238000004513 sizing Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
230000000153 supplemental effect Effects 0.000 description 1
239000003356 suture material Substances 0.000 description 1
210000000115 thoracic cavity Anatomy 0.000 description 1
230000002885 thrombogenetic effect Effects 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
229910052721 tungsten Inorganic materials 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
230000002792 vascular Effects 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
238000003466 welding Methods 0.000 description 1

Landscapes

Prostheses (AREA)

CA002302116A 1994-05-12 1994-08-15 Dispositif de soutien d'un transplant Abandoned CA2302116A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/241,476		1994-05-12
US08/241,476 US5628783A (en)	1991-04-11	1994-05-12	Bifurcated multicapsule intraluminal grafting system and method
CA002257663A CA2257663C (fr)	1994-05-12	1994-08-15	Systeme de transplantation intraluminale par multicapsules bifurquees et methode

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002257663A Division CA2257663C (fr)	1994-05-12	1994-08-15	Systeme de transplantation intraluminale par multicapsules bifurquees et methode

Publications (1)

Publication Number	Publication Date
CA2302116A1 true CA2302116A1 (fr)	1995-11-13

Family

ID=25680695

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002302116A Abandoned CA2302116A1 (fr)	1994-05-12	1994-08-15	Dispositif de soutien d'un transplant

Country Status (1)

Country	Link
CA (1)	CA2302116A1 (fr)

1994
- 1994-08-15 CA CA002302116A patent/CA2302116A1/fr not_active Abandoned

Legal Events

Date	Code	Title	Description
2000-03-31	EEER	Examination request
2003-01-13	FZDE	Dead

Publication	Publication Date	Title
US6355061B1 (en)	2002-03-12	Method for deploying bifurcated graft using a multicapsule system
US6682557B1 (en)	2004-01-27	Bifurcated multicapsule intraluminal grafting system and method
US6210434B1 (en)	2001-04-03	Multicapsule intraluminal grafting system and method
US7118594B2 (en)	2006-10-10	Bifurcated multicapsule intraluminal grafting system and method
US5749920A (en)	1998-05-12	Multicapsule intraluminal grafting system and method
US5693083A (en)	1997-12-02	Thoracic graft and delivery catheter
US5562728A (en)	1996-10-08	Endovascular grafting apparatus, system and method and devices for use therewith
US5275622A (en)	1994-01-04	Endovascular grafting apparatus, system and method and devices for use therewith
WO2000030562A1 (fr)	2000-06-02	Systeme et procede de greffe aorto-iliaque
CA2302116A1 (fr)	1995-11-13	Dispositif de soutien d'un transplant
AU738908B2 (en)	2001-09-27	Intraluminal graft
CA2300743A1 (fr)	1995-02-06	Systeme de greffe endoluminale avec plusieurs dispositifs de retention
AU9816898A (en)	1999-09-09	A balloon catheter